Circulatory effects of fenfluramine in obese hypertensive patients.
Publication
, Journal Article
Mroczek, WJ; Lee, WR; Finnerty, FA
Published in: Current therapeutic research, clinical and experimental
November 1974
Published In
Current therapeutic research, clinical and experimental
ISSN
0011-393X
Publication Date
November 1974
Volume
16
Issue
11
Start / End Page
1197 / 1202
Location
united states
Related Subject Headings
- Venous Pressure
- Vascular Resistance
- Time Factors
- Placebos
- Pharmacology & Pharmacy
- Obesity
- Male
- Hypertension
- Humans
- Heart Rate
Citation
APA
Chicago
ICMJE
MLA
NLM
Mroczek, W. J., Lee, W. R., & Finnerty, F. A. (1974). Circulatory effects of fenfluramine in obese hypertensive patients. Current Therapeutic Research, Clinical and Experimental, 16(11), 1197–1202.
Mroczek, W. J., W. R. Lee, and F. A. Finnerty. “Circulatory effects of fenfluramine in obese hypertensive patients.” Current Therapeutic Research, Clinical and Experimental 16, no. 11 (November 1974): 1197–1202.
Mroczek WJ, Lee WR, Finnerty FA. Circulatory effects of fenfluramine in obese hypertensive patients. Current therapeutic research, clinical and experimental. 1974 Nov;16(11):1197–202.
Mroczek, W. J., et al. “Circulatory effects of fenfluramine in obese hypertensive patients.” Current Therapeutic Research, Clinical and Experimental, vol. 16, no. 11, Nov. 1974, pp. 1197–202.
Mroczek WJ, Lee WR, Finnerty FA. Circulatory effects of fenfluramine in obese hypertensive patients. Current therapeutic research, clinical and experimental. 1974 Nov;16(11):1197–1202.
Published In
Current therapeutic research, clinical and experimental
ISSN
0011-393X
Publication Date
November 1974
Volume
16
Issue
11
Start / End Page
1197 / 1202
Location
united states
Related Subject Headings
- Venous Pressure
- Vascular Resistance
- Time Factors
- Placebos
- Pharmacology & Pharmacy
- Obesity
- Male
- Hypertension
- Humans
- Heart Rate